Concepts (75)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Strabismus | 12 | 2021 | 30 | 5.250 |
Why?
|
| Oculomotor Muscles | 10 | 2023 | 15 | 4.840 |
Why?
|
| Eye Movements | 12 | 2023 | 47 | 4.530 |
Why?
|
| Vision, Binocular | 13 | 2021 | 51 | 3.400 |
Why?
|
| Fixation, Ocular | 4 | 2020 | 40 | 2.290 |
Why?
|
| Macaca mulatta | 16 | 2020 | 126 | 2.260 |
Why?
|
| Saccades | 5 | 2021 | 17 | 1.890 |
Why?
|
| Disease Models, Animal | 12 | 2024 | 242 | 1.870 |
Why?
|
| Exotropia | 3 | 2019 | 3 | 1.690 |
Why?
|
| Animals | 19 | 2024 | 1817 | 1.430 |
Why?
|
| Motor Neurons | 5 | 2023 | 12 | 1.240 |
Why?
|
| Superior Colliculi | 2 | 2019 | 2 | 1.220 |
Why?
|
| Pursuit, Smooth | 6 | 2023 | 17 | 1.210 |
Why?
|
| Ophthalmologic Surgical Procedures | 2 | 2018 | 2 | 1.170 |
Why?
|
| Nystagmus, Pathologic | 4 | 2019 | 4 | 0.810 |
Why?
|
| Visual Acuity | 2 | 2021 | 179 | 0.780 |
Why?
|
| Ocular Motility Disorders | 1 | 2021 | 3 | 0.770 |
Why?
|
| Vision, Monocular | 1 | 2021 | 16 | 0.760 |
Why?
|
| Electric Stimulation | 2 | 2019 | 24 | 0.710 |
Why?
|
| Amblyopia | 1 | 2020 | 17 | 0.700 |
Why?
|
| Convergence, Ocular | 1 | 2019 | 13 | 0.650 |
Why?
|
| Neuronal Plasticity | 1 | 2018 | 21 | 0.610 |
Why?
|
| Neurons | 1 | 2019 | 131 | 0.580 |
Why?
|
| Nystagmus, Optokinetic | 1 | 2017 | 2 | 0.570 |
Why?
|
| Oculomotor Nerve | 3 | 2011 | 4 | 0.570 |
Why?
|
| Adaptation, Ocular | 1 | 2016 | 9 | 0.540 |
Why?
|
| Muscimol | 2 | 2013 | 3 | 0.460 |
Why?
|
| Administration, Intranasal | 2 | 2024 | 11 | 0.460 |
Why?
|
| Cerebellar Nuclei | 1 | 2013 | 1 | 0.440 |
Why?
|
| Mesencephalon | 1 | 2012 | 9 | 0.400 |
Why?
|
| Interstitial Cells of Cajal | 1 | 2010 | 1 | 0.360 |
Why?
|
| GABA Agonists | 1 | 2010 | 2 | 0.360 |
Why?
|
| Male | 4 | 2024 | 2770 | 0.290 |
Why?
|
| Antibodies, Viral | 1 | 2024 | 14 | 0.230 |
Why?
|
| Functional Laterality | 2 | 2016 | 38 | 0.220 |
Why?
|
| Nanoparticles | 1 | 2024 | 74 | 0.210 |
Why?
|
| Electrophysiology | 2 | 2012 | 23 | 0.200 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 97 | 0.170 |
Why?
|
| Female | 3 | 2024 | 2816 | 0.160 |
Why?
|
| Vision Disparity | 1 | 2019 | 26 | 0.160 |
Why?
|
| Young Adult | 1 | 2021 | 852 | 0.140 |
Why?
|
| Statistics as Topic | 1 | 2016 | 10 | 0.140 |
Why?
|
| Postoperative Period | 1 | 2016 | 5 | 0.140 |
Why?
|
| Middle Aged | 1 | 2021 | 1100 | 0.140 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2016 | 4 | 0.140 |
Why?
|
| Fovea Centralis | 1 | 2017 | 29 | 0.140 |
Why?
|
| Motion Perception | 1 | 2017 | 47 | 0.130 |
Why?
|
| Paresis | 1 | 2016 | 4 | 0.130 |
Why?
|
| Time Factors | 1 | 2016 | 176 | 0.130 |
Why?
|
| Humans | 3 | 2024 | 5485 | 0.120 |
Why?
|
| Adult | 1 | 2021 | 1687 | 0.120 |
Why?
|
| Cricetinae | 2 | 2024 | 21 | 0.120 |
Why?
|
| Brain | 1 | 2016 | 286 | 0.100 |
Why?
|
| Accommodation, Ocular | 1 | 2012 | 36 | 0.100 |
Why?
|
| Sensory Receptor Cells | 1 | 2011 | 2 | 0.100 |
Why?
|
| Animals, Newborn | 1 | 2011 | 37 | 0.090 |
Why?
|
| Mice | 2 | 2024 | 719 | 0.090 |
Why?
|
| Microinjections | 1 | 2010 | 2 | 0.090 |
Why?
|
| Stereotaxic Techniques | 1 | 2010 | 6 | 0.090 |
Why?
|
| Motor Cortex | 1 | 2010 | 22 | 0.090 |
Why?
|
| Models, Biological | 1 | 2011 | 131 | 0.090 |
Why?
|
| Antigens, Viral | 1 | 2024 | 4 | 0.060 |
Why?
|
| Mesocricetus | 1 | 2024 | 4 | 0.060 |
Why?
|
| Antibodies, Neutralizing | 1 | 2024 | 7 | 0.060 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2024 | 4 | 0.060 |
Why?
|
| Nucleotides, Cyclic | 1 | 2024 | 4 | 0.060 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2024 | 11 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 1 | 2024 | 22 | 0.060 |
Why?
|
| Antiviral Agents | 1 | 2024 | 17 | 0.060 |
Why?
|
| Immunoglobulin G | 1 | 2024 | 26 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2024 | 49 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 1 | 2024 | 195 | 0.050 |
Why?
|
| Rats | 1 | 2024 | 251 | 0.050 |
Why?
|
| Delayed-Action Preparations | 1 | 2016 | 5 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2016 | 212 | 0.030 |
Why?
|